- Home
- OSCR vs PCVX Comparison
OSCR vs PCVX Comparison
Compare OSCR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSCR
- PCVX
- Stock Information
- Founded
- OSCR 2012
- PCVX 2013
- Country
- OSCR United States
- PCVX United States
- Employees
- OSCR N/A
- PCVX N/A
- Industry
- OSCR Accident &Health Insurance
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- OSCR Finance
- PCVX Health Care
- Exchange
- OSCR Nasdaq
- PCVX Nasdaq
- Market Cap
- OSCR 4.6B
- PCVX 4.0B
- IPO Year
- OSCR 2021
- PCVX 2020
- Fundamental
- Price
- OSCR $19.10
- PCVX $32.59
- Analyst Decision
- OSCR Sell
- PCVX Strong Buy
- Analyst Count
- OSCR 7
- PCVX 8
- Target Price
- OSCR $12.07
- PCVX $114.17
- AVG Volume (30 Days)
- OSCR 16.7M
- PCVX 1.6M
- Earning Date
- OSCR 11-06-2025
- PCVX 11-04-2025
- Dividend Yield
- OSCR N/A
- PCVX N/A
- EPS Growth
- OSCR N/A
- PCVX N/A
- EPS
- OSCR N/A
- PCVX N/A
- Revenue
- OSCR $10,726,126,000.00
- PCVX N/A
- Revenue This Year
- OSCR $33.98
- PCVX N/A
- Revenue Next Year
- OSCR N/A
- PCVX N/A
- P/E Ratio
- OSCR N/A
- PCVX N/A
- Revenue Growth
- OSCR 48.29
- PCVX N/A
- 52 Week Low
- OSCR $11.20
- PCVX $27.66
- 52 Week High
- OSCR $23.79
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- OSCR 59.59
- PCVX 53.03
- Support Level
- OSCR $16.91
- PCVX $31.47
- Resistance Level
- OSCR $20.77
- PCVX $33.16
- Average True Range (ATR)
- OSCR 1.12
- PCVX 1.37
- MACD
- OSCR -0.09
- PCVX 0.07
- Stochastic Oscillator
- OSCR 67.06
- PCVX 67.76
About OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.